about
Dietary, metabolic, and potentially environmental modulation of the lysine acetylation machineryDietary factors and epigenetic regulation for prostate cancer preventionMolecular cloning and promoter analysis of downregulated in adenoma (DRA)Could Sirt1-mediated epigenetic effects contribute to the longevity response to dietary restriction and be mimicked by other dietary interventions?Dietary garlic and hip osteoarthritis: evidence of a protective effect and putative mechanism of actionHistone deacetylase inhibitors potentiate photodynamic therapy in colon cancer cells marked by chromatin-mediated epigenetic regulation of CDKN1A.Epigenetic targets of bioactive dietary components for cancer prevention and therapy.Dietary manipulation of histone structure and function.Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrestRegulation of VDR Expression in Apc-Mutant Mice, Human Colon Cancers and Adenomas.Metabolism as a key to histone deacetylase inhibition.The molecular basis that unifies the metabolism, cellular uptake and chemopreventive activities of dietary isothiocyanates.Butyrate delivered by butyrylated starch increases distal colonic epithelial apoptosis in carcinogen-treated rats.Dose-dependent effects of R-sulforaphane isothiocyanate on the biology of human mesenchymal stem cells, at dietary amounts, it promotes cell proliferation and reduces senescence and apoptosis, while at anti-cancer drug doses, it has a cytotoxic effeButyrate induced cell cycle arrest in bovine cells through targeting gene expression relevant to DNA replication apparatus.Emerging Molecular Pathways Governing Dietary Regulation of Neural Stem Cells during Aging.Influence of maternal obesity, diet and exercise on epigenetic regulation of adipocytes.The influence of epigenetics in relation to oral health.Impact of Epigenetic Dietary Components on Cancer through Histone Modifications.Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors.Genetic and epigenetic cancer chemoprevention on molecular targets during multistage carcinogenesis.Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity.Combination treatment with resveratrol and sulforaphane induces apoptosis in human U251 glioma cells.Sodium butyrate induces human colon carcinoma HT-29 cell apoptosis through a mitochondrial pathway.Sulforaphane-Induced Cell Cycle Arrest and Senescence are accompanied by DNA Hypomethylation and Changes in microRNA Profile in Breast Cancer Cells.Histone deacetylase inhibitors promote eNOS expression in vascular smooth muscle cells and suppress hypoxia-induced cell growth.Epigenetic changes in colorectal cancerSulforaphane epigenetically enhances neuronal BDNF expression and TrkB signaling pathways.The dietary histone deacetylase inhibitor sulforaphane induces human beta-defensin-2 in intestinal epithelial cells.Stereoselective HDAC inhibition from cysteine-derived zinc-binding groups.
P2860
Q21296850-81928C43-D24A-4670-8427-FF525397FADEQ26991774-E35B7E81-9D99-4F9C-8502-0A7C2DB32CAEQ28244049-639A5ED1-C6F5-410A-A9D1-662C8828179FQ33617224-EDC7FA49-81EF-4C38-B83B-43E109127BFBQ33766886-D7B5B0D6-D775-45BC-9945-043AEEFA7077Q33781317-86FE2B01-EB54-4077-A862-D1FBB9B5BF7AQ34508252-D4C643D2-0A4B-4D71-B952-55BA9E154B73Q34898711-E6A40741-27CE-41F2-B026-B902DF96D607Q35554585-63752C0B-543E-420B-A1D6-543316C42F3AQ35562888-68122F1F-6B99-4B69-9BD8-84D72D1ADD17Q35661981-454C2262-31FC-4DAF-9BC7-FBEE01CE0F27Q35747310-8D0CEBDF-2F5D-4B39-8302-11509FE2D83CQ35747315-2FA0E8A3-FF26-4E27-AA50-E92CDFDF2E1DQ35853652-880D3984-0264-4F4B-95BC-AC3D7876A559Q37321856-D6C02893-1C3C-4425-B1E5-2B2ADD897F4EQ37611719-5D737BF5-8B15-408F-9389-945C71CB5F8BQ37710116-50D4838F-1DD9-4148-87CD-2DFD519EBD4AQ38111414-AE8927EA-37DB-4A17-9E25-E4533E5A1BDDQ38428453-0181FB76-D4FB-4F55-840D-06F66A3F5390Q38572921-FFA16361-777F-40A1-835C-1A5DABBE89D9Q38931011-66FCB57C-6ECA-4DD9-98F7-12269DC5D4F1Q39418780-24423F6E-F01C-4CCE-98D7-6C2F4C29DA40Q39811872-9244803E-8ED7-429D-978E-A1DE6F4EBC7AQ39827064-CA1A1EDD-5230-4CF0-A83D-D48E5E6EA451Q41174242-9E419368-A3C5-488A-94DB-5282DFAAC301Q41520325-0D669880-9E12-46B4-9AE9-3C9139F51C80Q41973340-4D592FFD-53D2-4DDF-BFEA-A72AE07FED05Q43650001-25824DA0-27A8-435B-AA9F-D60E1A52F877Q45796015-2A35EE63-8990-4BD2-851E-34C59A7917F8Q45955357-91A876A6-D0BD-43A8-8182-C029F2C0CA72
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Dietary agents as histone deacetylase inhibitors.
@ast
Dietary agents as histone deacetylase inhibitors.
@en
type
label
Dietary agents as histone deacetylase inhibitors.
@ast
Dietary agents as histone deacetylase inhibitors.
@en
prefLabel
Dietary agents as histone deacetylase inhibitors.
@ast
Dietary agents as histone deacetylase inhibitors.
@en
P2093
P2860
P356
P1476
Dietary agents as histone deacetylase inhibitors.
@en
P2093
Melinda C Myzak
Roderick H Dashwood
P2860
P304
P356
10.1002/MC.20224
P577
2006-06-01T00:00:00Z